About this event
The road to launching a novel drug to the market is long and winding. Many different methods and models are used during the development pipeline to evaluate the drug candidates. The Zebrafish xenograft, ZTX™ model for evaluation of efficacy is one of them and one that is fairly new and for many unknown.
In this webinar we will present the ZTX model and discuss the pros and cons and compared to other models commonly used in drug development today like mice in vivo, organoids and in vitro models.
Speaker is Dr Anna Erkstam, PhD
We are a contract research organization (CRO) that increase the speed for your pre-clinical drug discovery.
Share this event